ARID1A and neoplasm: While certain tumor types did have higher rates of ARID1A alterations in the tissue than we found in the blood, others had lower frequencies: breast, ~5% vs. 6.1%; head and neck, ~4.5% vs. 5.3% (tissue versus blood).